<DOC>
	<DOC>NCT01096160</DOC>
	<brief_summary>This study will evaluate the safety and tolerability of MK8266.</brief_summary>
	<brief_title>A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8266 (8266-002)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Subject is male with essential hypertension (high blood pressure) Subject is in good general health (with the exception of hypertension) Subject is a nonsmoker Subject has a history of stroke, chronic seizure, or major neurological disease Subject has a functional disability that can interfere with rising from a seated position to the standing position Subject has any history of a bleeding or clotting disorder Subject has a history of cancer Subject is unable to refrain from or anticipates the use of any prescription or nonprescription medication Subject consumes excessive amounts of alcohol or caffeinated beverages daily</criteria>
	<gender>Male</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>58 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Hypertension</keyword>
</DOC>